Global Proteomics Consortium Reveals Immune Signature and Disease-Specific Markers in Brain Disorders
The GNPC’s report confirms an inflammation-related APOE4 signature across Alzheimer’s, Parkinson’s, frontotemporal dementia, ALS, setting the stage for developing multi-disease blood tests.
